Home > Income Statement > ORCHID PHARMA

ORCHID PHARMA
Consolidated Net Profit

    Back to Income Statement
ORCHID PHARMA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for ORCHID PHARMA
Please provide your vote to see the results

ORCHID PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹100 Cr₹92 Cr₹46 Cr₹-1.95 Cr₹-117 Cr

What is the latest Consolidated Net Profit of ORCHID PHARMA ?

The latest Consolidated Net Profit ratio of ORCHID PHARMA is ₹100 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹100 Cr
Mar2024₹92 Cr
Mar2023₹46 Cr
Mar2022₹-1.95 Cr
Mar2021₹-117 Cr

How is Consolidated Net Profit of ORCHID PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹100 Cr
8.13
Mar2024 ₹92 Cr
98.99
Mar2023 ₹46 Cr
Positive
Mar2022 ₹-1.95 Cr
Negative
Mar2021 ₹-117 Cr -

Compare Consolidated Net Profit of peers of ORCHID PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ORCHID PHARMA ₹4,882.4 Cr -7.5% -2.6% 33.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹468,842.0 Cr 1.1% 4.6% 14.2% Stock Analytics
DIVIS LABORATORIES ₹193,860.0 Cr 0.6% 8.3% 8.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹192,687.0 Cr 6.3% 12.2% 45.5% Stock Analytics
CIPLA ₹112,593.0 Cr -1.7% -2.8% -4% Stock Analytics
DR REDDYS LABORATORIES ₹97,364.9 Cr -3.7% -10.4% -6% Stock Analytics


ORCHID PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
ORCHID PHARMA

-7.5%

-2.6%

33.7%

SENSEX

-1%

-0.9%

-7.5%


You may also like the below Video Courses